Guardant Health Stock Beta
| GH Stock | USD 31.67 0.54 1.73% |
Guardant Health fundamentals help investors to digest information that contributes to Guardant Health's financial success or failures. It also enables traders to predict the movement of Guardant Stock. The fundamental analysis module provides a way to measure Guardant Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardant Health stock.
Guardant | Beta |
Guardant Health Company Beta Analysis
Guardant Health's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Guardant Health Beta | 1.11 |
Most of Guardant Health's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardant Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Guardant Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Guardant Health is extremely important. It helps to project a fair market value of Guardant Stock properly, considering its historical fundamentals such as Beta. Since Guardant Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Guardant Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Guardant Health's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Guardant Health has a Beta of 1.106. This is 28.6% higher than that of the Health Care Providers & Services sector and 23.19% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Guardant Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardant Health's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics of similar companies.Guardant Health is currently under evaluation in beta category among its peers.
Guardant Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Guardant Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Guardant Health's managers, analysts, and investors.Environmental | Governance | Social |
Guardant Health Institutional Holders
Institutional Holdings refers to the ownership stake in Guardant Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Guardant Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Guardant Health's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 2.8 M | Parkwood Llc | 2024-09-30 | 2.8 M | State Street Corp | 2024-09-30 | 2.8 M | Fuller & Thaler Asset Management Inc | 2024-09-30 | 2.2 M | Temasek Holdings Ltd. | 2024-09-30 | 2.1 M | Fidelity International Ltd | 2024-09-30 | 2.1 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.7 M | Ark Investment Management Llc | 2024-09-30 | 1.5 M | Fmr Inc | 2024-09-30 | 1.5 M | Vanguard Group Inc | 2024-09-30 | 11.7 M | Blackrock Inc | 2024-06-30 | 11.2 M |
Guardant Health returns are very sensitive to returns on the market. As the market goes up or down, Guardant Health is expected to follow.
Guardant Fundamentals
| Return On Equity | -6.09 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.61) % | ||||
| Current Valuation | 4.18 B | ||||
| Shares Outstanding | 123.56 M | ||||
| Shares Owned By Insiders | 4.56 % | ||||
| Shares Owned By Institutions | 95.44 % | ||||
| Number Of Shares Shorted | 9.17 M | ||||
| Price To Earning | (12.01) X | ||||
| Price To Book | 55.67 X | ||||
| Price To Sales | 5.54 X | ||||
| Revenue | 563.95 M | ||||
| Gross Profit | 293.21 M | ||||
| EBITDA | (433.31 M) | ||||
| Net Income | (479.45 M) | ||||
| Cash And Equivalents | 853.69 M | ||||
| Cash Per Share | 8.35 X | ||||
| Total Debt | 1.35 B | ||||
| Debt To Equity | 4.32 % | ||||
| Current Ratio | 6.18 X | ||||
| Book Value Per Share | (0.49) X | ||||
| Cash Flow From Operations | (324.98 M) | ||||
| Short Ratio | 4.07 X | ||||
| Earnings Per Share | (4.28) X | ||||
| Price To Earnings To Growth | (0.66) X | ||||
| Target Price | 43.2 | ||||
| Number Of Employees | 1.77 K | ||||
| Beta | 1.11 | ||||
| Market Capitalization | 3.84 B | ||||
| Total Asset | 1.79 B | ||||
| Retained Earnings | (2.14 B) | ||||
| Working Capital | 1.14 B | ||||
| Current Asset | 219.68 M | ||||
| Current Liabilities | 24.24 M | ||||
| Net Asset | 1.79 B |
About Guardant Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Guardant Health Piotroski F Score and Guardant Health Altman Z Score analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.